We led a Sustainability Accounting Standards Board (SASB) investor collaboration that successfully encouraged JNJ to strengthen its sustainability disclosures by including its first SASB Index, addressing key material topics such as affordability and pricing, drug safety, ethical marketing, and packaging lifecycle management, among others.